Population
We recruited 204 patients. For 26 (12.7%) we had no data on failure (2 died, 24 could not be reached e.g. moved and 2 for other reasons). In the analysis of pain and physical functioning, we included 172 (84%) patients (in addition to the lost patients above, 6 more did not respond any question on patient reported outcomes).
Table 1 shows the baseline characteristics.
Table 1
Predictive factor
|
|
Age (mean ± SD)
|
51.39 (± 17.05)
|
Female
|
90 (44.1%)
|
BMI (mean ± SD)
|
26.01 (± 5.85)
|
Obesity (BMI ≥ 30)
|
37 (18.1%)
|
Smoker
|
75 (36.8%)
|
Smoking intensity (package years, mean ± SD)
|
18.62 (± 17.66)
|
Smoker type (≥ 10 package years)
|
47 (23%)
|
Diabetes (yes/no)*
|
11 (5.4%)
|
Peripheral arterial disease
|
5 (2.5%)
|
Open fracture
|
29 (14.2%)
|
Localization
|
|
Tibia
|
88 (43.1%)
|
Femur
|
49 (24.0%)
|
Malleolus
|
27 (13.2%)
|
Calcaneus
|
17 (8.3%)
|
Fibula
|
23 (11.3%)
|
* type I and II not differentiated; BMI: body mass index; SD: standard deviation |
Primary outcome: failure
Table 2 shows the results of the multivariate analysis. Figures 1 and 2 show the unadjusted survival curves for BMI and open fracture, respectively.
Table 2
Cox regression model of predictive factors for failure
Predictive factor
|
Hazard Ratio (95% confidence interval)
|
Age (≥ 65 vs < 65)
|
1.51 (0.63 to 3.60)
|
Female (yes vs no)
|
1.25 (0.55 to 2.81)
|
BMI (≥ 30 vs < 30)
|
2.54 (1.12 to 5.80)
|
Package years (≥ 10 vs < 10)
|
1.19 (0.53 to 2.70)
|
Open fracture (yes vs. no)
|
5.36 (2.25 to 12.75)
|
Diabetes (yes vs. no)
|
1.07 (0.24 to 4.86)
|
Peripheral arterial disease (yes vs. no)
|
2.44 (0.29 to 20.72)
|
Overall, we observed a failure in 33 patients (16.2%). Of these, 16 had an implant failure, 8 an additional surgery for reposition and 17 a nonunion. Four of the 33 failure patients received antibiotics for treating wound infection. Most of the failures (compare Figs. 1 and 2) occurred within the first 3 months. Obesity and open fractures increased the risk of failure.
Age, female gender and smoking of more than ≥ 10 package years increased failure risk but statistical uncertainty was high for these factors. Diabetes was not associated with a higher risk of failure. Explorative subgroup analysis suggested that the negative influence of BMI was large in femur fractures but that the effect was uncertain in fractures below the knee (adjusted HR 6.18; 95%CI 1.42 to 26.95 vs adjusted HR 0.77 95%CI 0.24 to 2.44). The influence of the other factors was similar in both localizations (data not shown).
Secondary outcome: pain
Table 3 shows the results of the MANOVA. After 6 months, 27% of patients had no pain. Average pain after 6 months was 2.43 (95%CI 2.08 to 2.79) and the median pain was 2 (inter-quartile-range 2–4). All variables had a marginal impact on pain.
Table 3
Variables influencing pain
Variable
|
Regression coefficient (95% confidence interval)*
|
Intercept
|
2.89 (1.76 to 4.00)
|
Age (≥ 65)
|
-0.04 (-0.92 to 0.84)
|
Female
|
-0.02 (-0.71 to 0.68)
|
BMI (≥ 30)
|
-0.36 (-0.51 to 1.24)
|
Package years (≥ 10)
|
0.06 (-0.72 to 0.82)
|
Diabetes (yes)
|
0.79 (-0.70 to 2.28)
|
Peripheral arterial disease (yes)
|
0.48 (-1.60 to 2.56)
|
Open fracture (yes)
|
0.57 (-0.36 to 1.51)
|
Localization (femur)
|
-0.54 (-1.37 to 0.29)
|
*minus indicates a positive impact (reduction in pain) |
Secondary outcome: physical functioning
Results of the MANOVA for physical functioning are presented in Table 4.No difficulties in any physical task (climbing one stair, climbing more stairs, stooping) after 6 months were reported by 20% of patients. The median physical functioning score was 6 (lower quartile: 5; upper quartile: 8). Expectedly, physical functioning was reduced by the same factors that increased failure rates (BMI and open fracture). In addition, patients with peripheral arterial diseases reported more difficulties with physical functioning.
Although, this targeted sample size was not reached, we nearly satisfied the number of observations needed (33 instead of 35) per variable because the failure rate was higher than expected.
Table 4
Variables influencing physical functioning
Variable
|
Regression coefficient (95% confidence interval)*
|
Intercept
|
6.97 (6.13 to 7.81)
|
Age (≥ 65)
|
-0.16 (-0.80 to 0.48)
|
Female
|
-0.44 (-0.95 to 0.07)
|
BMI (≥ 30)
|
-0.70 (-1.38 to -0.03)
|
Package years (≥ 10)
|
-0.18 ( -0.84 to 0.48)
|
Diabetes (yes)
|
-0.10 (-1.21 to 1.01)
|
Peripheral arterial disease (yes)
|
-1.80 (-3.38 to -0.21)
|
Open fracture (yes)
|
-0.80 (-1.54 to -0.07)
|
Localization (femur)
|
0.14 (-0.56 to 0.82)
|
*minus indicates a negative impact (more difficulties) |